Dh. Suh et al., Changes of skin blood flow and color on lesional and control sites during PUVA therapy for psoriasis, J AM ACAD D, 44(6), 2001, pp. 987-994
Background: Although the colors of psoriatic lesions, largely determined by
erythema and scales, are important clinical indicators, expressing them in
an objective manner is difficult. Cutaneous blood flow (CBF) also affects
erythema. Serial measurement of these parameters during phototherapy was al
most nonexistent.
Objective: The objectives of our study were to observe the changes of color
parameters and the CBF of psoriatic lesions during PUVA therapy and to det
ermine their clinical significance.
Methods: CBF, measured by laser Doppler flowmetry: and color parameters, me
asured by tristimulus colorimetry and reflectance spectrophotometry, were a
ssessed in 13 patients with psoriasis who received PUVA therapy.
Results: The values of CBF, erythema index (EI), and a* (color parameter re
presenting red-green axis) in psoriatic lesions were significantly differen
t from those observed in the control sites before therapy The parameters of
psoriatic lesions normalized according to the clinical improvement and app
roached those of the control sites as PUVA therapy progressed. The values o
f melanin index (MI), L* (color parameter representing white-black axis), a
nd b* (color parameter representing yellow-blue axis) showed no significant
difference between the psoriatic plaques and the control sites. They all d
isplayed changes toward darkening and indicated tanning induced by PUVA the
rapy. Serial changes presented a generally unidirectional pattern in the co
ntrol sites. However, this was not always the case in psoriatic lesions bec
ause scale, infiltration, and erythema also affected the measurement of blo
od flow and the color of the skin.
Conclusion: Color parameters and CBF were closely related with clinical imp
rovement according to consecutive phototherapy. They may serve as objective
indices for the visible morphology and underlying lesional pathophysiology
of psoriasis.